News | Radiation Therapy | June 07, 2019

ASTRO Applauds New Prior Authorization Legislation

H.R. 3107 designed to increase transparency in prior authorization process and help curb unnecessary delays for Medicare Advantage patients

ASTRO Applauds New Prior Authorization Legislation

June 7, 2019 — The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of bipartisan federal legislation that would rein in restrictive prior authorization practices. The society said these practices unnecessarily delay patient access to critical cancer treatments.

The Improving Seniors’ Timely Access to Care Act of 2019 (H.R. 3107), introduced by Rep. Suzan DelBene (D-Wash.), Rep. Mike Kelly (R-Pa.), Rep. Roger Marshall, M.D., (R-Kan.) and Rep. Ami Bera, M.D., (D-Calif.) is an important first step toward reforming prior authorization practices, according to ASTRO.

ASTRO Chair Paul Harari, M.D., FASTRO, called on Congress to support the bill, which aims to reduce obstacles to high-quality cancer care. “Restrictive prior authorization practices can cause unnecessary, stressful and potentially life-threatening delays for cancer patients,” said Harari. "While the system was designed as a path to streamline and strengthen access to treatments, it is in fact frequently harmful to cancer patients who are prescribed radiation therapy, particularly by wasting precious time and causing immense anxiety. We applaud Reps. DelBene, Kelly, Marshall and Bera for their leadership in introducing this bipartisan legislation to bring needed reform to a broken system.”

In a recent ASTRO nationwide survey of radiation oncologists, more than nine in 10 physicians said that their patients are kept from life-saving treatments due to delays caused by prior authorization, and one-third said the average delay lasts longer than a week. These delays cause added stress and anxiety to patients already concerned about their health, and they are cause for alarm given research that links each week of delay in starting cancer therapy with a 1.2 to 3.2 percent increased risk of death, depending on cancer type.

If passed, this legislation would increase transparency in the prior authorization process and help curb unnecessary delays for patients covered by Medicare Advantage (MA) plans, said ASTRO in the statement. Under the proposed new bill, the MA plans would need to provide relevant information including an annual disclosure of medical treatments subject to prior authorization, the percentage of requests that are approved and denied, and the average time for approval. The legislation also provides for an electronic prior authorization process, which would help streamline decisions and avoid unnecessary delays for certain routine procedures.

Radiation oncology and cancer patients have been particularly hard hit by prior authorization’s unnecessary interference in care decisions, ASTRO said. Radiation oncologists increasingly are restricted from exercising their clinical judgment about what is in the best interest of their patients, yet they are held accountable for the outcomes of treatments where decisions have been taken out of their hands.

The findings from ASTRO’s physician survey align with reports from the American Medical Association (AMA) and American Cancer Society that demonstrate the pervasiveness of prior authorization obstacles throughout the healthcare system. In late February ASTRO joined with the AMA and more than 100 other medical groups calling for prior authorization requirements in Medicare Advantage to align with the Consensus Statement on Improving the Prior Authorization Process authored jointly by leading provider and payer organizations. ASTRO said the new legislation codifies key components of the consensus statement between payers and providers.

For more information: www.astro.org

Related Content

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

News | Coronavirus (COVID-19) | July 09, 2020
July 9, 2020 — With increased lung CT exam paradigms being used in the current...
World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (...
Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress

Getty Images

News | Breast Imaging | July 09, 2020
July 9, 2020 — Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metast
At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 
Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane
At the American Association of Physicists in Medicine (AAPM) 201
Changes outlined in new draft U.S. Preventive Services Task Force (USPSTF) lung cancer screening recommendations will greatly increase the number of Americans eligible for screening and help medical providers save thousands more lives each year.

Image courtesy of Cerner

News | Lung Imaging | July 08, 2020
July 8, 2020 — Changes outlined in new draft U.S.
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different.
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam
Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.
The field of proton...